Chordate Medical Holding AB (publ) (K1Z.F)

0.0036 +0.0004 (+14.29%) As of 08:10AM CEST. Market open.

Chordate Medical Holding AB (publ)

KistagAngen 20B
Kista 164 40
Sweden
46 8 40 01 15 86
https://www.chordate.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 3

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Anders Weilandt	CEO & MD	N/A	N/A	1961
Mr. Niklas Lindecrantz	Chief Financial Officer	N/A	N/A	1968
Mr. Jan Lindberg	CTO and Head of R&D, Production & Quality	N/A	N/A	1956
Mr. Jan Hermansson	Chief Scientific Officer and Clinical Research & Medical Director	N/A	N/A	1956
Ms. Helena Ossmer Thedius	Sales & Marketing Manager	N/A	N/A	1976

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. Chordate Medical Holding AB (publ) was incorporated in 2014 and is based in Kista, Sweden.

Corporate governance

Chordate Medical Holding AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.